Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Colorectal Neoplasms

  Free Subscription


1 Am J Surg
7 Ann Surg Oncol
1 BMC Cancer
1 BMC Gastroenterol
1 Cancer
1 Cancer Res
2 Clin Cancer Res
1 Eur J Cancer
2 Gastroenterology
1 Int J Cancer
5 Int J Colorectal Dis
1 Int J Oncol
2 J Surg Oncol
1 Oncol Rep
1 Oncology
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Surg

  1. FAYANJU OM, Oyekunle T, Thomas SM, Ingraham KL, et al
    Modifiable patient-reported factors associated with cancer-screening knowledge and participation in a community-based health assessment.
    Am J Surg. 2023;225:617-629.
    PubMed         Abstract available

    Ann Surg Oncol

  2. CHILDERS CP, Uppal A, Tillman M, Chang GJ, et al
    Insurance Disparities in Access to Robotic Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2023 Mar 21. doi: 10.1245/s10434-023-13354.
    PubMed         Abstract available

  3. HONAKER MD, Irish W, Parikh AA, Snyder RA, et al
    Association of Rural Residence and Receipt of Guideline-Concordant Care for Locoregional Colon Cancer.
    Ann Surg Oncol. 2023 Mar 18. doi: 10.1245/s10434-023-13340.
    PubMed         Abstract available

  4. WEI AC
    Practice-Changing Evidence in Surgical Oncology 2021: Hepatobiliary Articles.
    Ann Surg Oncol. 2023;30:1960-1965.
    PubMed         Abstract available

  5. DIETZ MV, Ziekman MJ, van Kooten JP, Brandt-Kerkhof ARM, et al
    ASO Visual Abstract: Treatment and Survival Outcomes of Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
    Ann Surg Oncol. 2023;30:2057.

  6. NIKIFORCHIN A, Sardi A, King MC, Baron E, et al
    ASO Visual Abstract: Safety of Nephrectomy Performed During CRS/HIPEC-A Propensity Score-Matched Study.
    Ann Surg Oncol. 2023;30:2531.

  7. DIETZ MV, Ziekman MJ, van Kooten JP, Brandt-Kerkhof ARM, et al
    Treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
    Ann Surg Oncol. 2023;30:2048-2056.
    PubMed         Abstract available

  8. MANGIERI CW, Valenzuela CD, Solsky IB, Erali RA, et al
    Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?
    Ann Surg Oncol. 2023;30:2486-2493.
    PubMed         Abstract available

    BMC Cancer

  9. SLATER S, Bryant A, Chen HC, Begum R, et al
    ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C).
    BMC Cancer. 2023;23:257.
    PubMed         Abstract available

    BMC Gastroenterol

  10. LIU M, Liu SJ, Chen MJ, Ning T, et al
    A new modality of colorectal cancer screening based on chronic disease management.
    BMC Gastroenterol. 2023;23:78.
    PubMed         Abstract available


  11. GREEN BB
    Defensive information processing and nonadherence to health-protective behaviors.
    Cancer. 2023;129:1156-1158.
    PubMed         Abstract available

    Cancer Res

  12. MILLER AL, Perurena N, Gardner A, Hinoue T, et al
    DAB2IP is a bifunctional tumor suppressor that regulates wildtype RAS and inflammatory cascades in KRAS mutant colon cancer.
    Cancer Res. 2023 Mar 20:CAN-22-0370. doi: 10.1158/0008-5472.CAN-22-0370.
    PubMed         Abstract available

    Clin Cancer Res

  13. DING N, You AB, Yang H, Hu GS, et al
    A tumor suppressive-molecular axis EP300/circRERE/miR-6837-3p/MAVS activates type I interferon pathway and anti-tumor immunity to suppress colorectal cancer.
    Clin Cancer Res. 2023 Mar 23:CCR-22-3836. doi: 10.1158/1078-0432.CCR-22-3836.
    PubMed         Abstract available

  14. RAY AL, Saunders AS, Nofchissey RA, Reidy MA, et al
    Granulocyte colony stimulating factor is a novel mediator of T cell suppression and an immunotherapeutic target for women with colon cancer.
    Clin Cancer Res. 2023 Mar 23:CCR-22-3918. doi: 10.1158/1078-0432.CCR-22-3918.
    PubMed         Abstract available

    Eur J Cancer

  15. BOLHUIS K, Bond MJG, Van Amerongen MJ, Komurcu A, et al
    The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trial.
    Eur J Cancer. 2023;183:49-59.
    PubMed         Abstract available


  16. MOURADOV D, Greenfield P, Li S, In EJ, et al
    Onco-microbial community profiling identifies clinico-molecular and prognostic subtypes of colorectal cancer.
    Gastroenterology. 2023 Mar 16:S0016-5085(23)00493.
    PubMed         Abstract available

  17. FORBES N
    Impact of Screening-related Sigmoidoscopy on the Incidence and Mortality of Colorectal Cancer.
    Gastroenterology. 2023 Mar 18:S0016-5085(23)00509.

    Int J Cancer

  18. LI J, Qin S, Zhang S, Lu Y, et al
    Serum vitamin D concentration, vitamin D-related polymorphisms, and colorectal cancer risk.
    Int J Cancer. 2023 Mar 22. doi: 10.1002/ijc.34521.
    PubMed         Abstract available

    Int J Colorectal Dis

  19. LIU XR, Tong Y, Li ZW, Liu F, et al
    Do colorectal cancer patients with a postoperative stoma have sexual problems? A pooling up analysis of 2566 patients.
    Int J Colorectal Dis. 2023;38:79.
    PubMed         Abstract available

  20. IGUCHI K, Watanabe J, Suwa Y, Chida K, et al
    The effect of preoperative endoscopic tattooing using India ink on lymph node yield in laparoscopic colectomy for stage I right-sided colon cancer.
    Int J Colorectal Dis. 2023;38:77.
    PubMed         Abstract available

  21. UYLAS U, Gundogdu R, Sumer F, Samdanci E, et al
    Incidental cancer in colectomy specimens from patients with familial adenomatous polyposis: single centre experience and literature review.
    Int J Colorectal Dis. 2023;38:76.
    PubMed         Abstract available

  22. YOKOTA M, Morikawa A, Matsuoka H, Muto J, et al
    Is frequent measurement of tumor markers beneficial for postoperative surveillance of colorectal cancer?
    Int J Colorectal Dis. 2023;38:75.
    PubMed         Abstract available

  23. FAN CW, Chen PH, Jhou HJ, Cheng YC, et al
    Negative pressure wound management in perineal wound status post abdominoperineal resection and extralevator abdominoperineal excision: a meta-analysis and trial sequential analysis.
    Int J Colorectal Dis. 2023;38:73.
    PubMed         Abstract available

    Int J Oncol

  24. CUI K, Wu H, Zhang L, Li H, et al
    A novel lncRNA 495810 promotes the aerobic glycolysis in colorectal cancer by stabilizing pyruvate kinase isozyme M2.
    Int J Oncol. 2023;62:58.
    PubMed         Abstract available

    J Surg Oncol

  25. MANKARIOUS MM, Portolese AC, Hoskins MA, Deutsch MJ, et al
    Neoadjuvant chemotherapy does not increase risk for anastomotic leak for simultaneous resection of primary colon cancer with synchronous liver metastasis: A NSQIP-colectomy analysis.
    J Surg Oncol. 2023 Mar 20. doi: 10.1002/jso.27242.
    PubMed         Abstract available

  26. CUK P, Simonsen RM, Sherzai S, Buchbjerg T, et al
    Surgical efficacy and learning curves of laparoscopic complete mesocolic excision with intracorporeal anastomosis for right-sided colon cancer: A retrospective two-center cohort study.
    J Surg Oncol. 2023 Mar 18. doi: 10.1002/jso.27230.
    PubMed         Abstract available

    Oncol Rep

  27. SUN LB, Zhao SF, Zhu JJ, Han Y, et al
    [Retracted] Long noncoding RNA UCID sponges miR‑152‑3p to promote colorectal cancer cell migration and invasion via the Wnt/beta‑catenin signaling pathway.
    Oncol Rep. 2023;49:92.
    PubMed         Abstract available


  28. MAUREL JM, Tamayo MB, Pitargue R, Ong-Cornel AB, et al
    Practical notes on the current ESMO consensus guidelines for the management of patients with metastatic colorectal cancer in resource-constrained environments of low- to middle-income countries.
    Oncology. 2023 Mar 23. doi: 10.1159/000530275.
    PubMed         Abstract available

    PLoS One

  29. FAN F, Ghosh S, Powell R, Roszik J, et al
    Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo.
    PLoS One. 2023;18:e0281063.
    PubMed         Abstract available

  30. JEON J, Han EY, Jung I
    MOPA: An integrative multi-omics pathway analysis method for measuring omics activity.
    PLoS One. 2023;18:e0278272.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.